The FDA has a new warning about GLP-1s and vision loss. Should you worry? — Live Feedhttps://www.live-feeds.com/feed/the-fda-has-a-new-warning-about-glp-1s-and-vision-loss-should-you-worryContinuously updated, source-cited coverage. FDA adds rare vision-loss warning to Ozempic, Wegovy, Zepbound labelshttps://www.live-feeds.com/feed/the-fda-has-a-new-warning-about-glp-1s-and-vision-loss-should-you-worryhttps://www.live-feeds.com/feed/the-fda-has-a-new-warning-about-glp-1s-and-vision-loss-should-you-worry#u199498Fri, 13 Nov 2026 22:30:51 +0000The FDA has ordered new warning labels on Ozempic, Wegovy and Zepbound about a rare eye condition that can cause permanent vision loss. The condition is non-arteritic anterior ischemic optic neuropathy, or NAION, which blocks blood flow to the optic nerve. Doctors do not yet know how GLP-1 drugs might contribute to the effect, and the agency says the warning is issued out of an abundance of caution. Patients should not stop medication without consulting a clinician.Why it mattersGLP-1 medications are widely prescribed for diabetes and weight loss, so any vision-related safety signal affects mi